Approval · Notice of Compliance 32332 · 2023
MIRAPEX: Notice of Compliance 32332
Issued December 12, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32332
- Date
- December 12, 2023
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Update to the Product Monograph. Update to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIRAPEX | Not yet assigned | — |
Medicinal ingredients
- PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 0.25 MG per TAB
- PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE 0.125 MG per TAB